Inclinix, a contract research organization that focuses on enrollment for clinical trials, has added several executives to its management team.

Steven Agnoff is now vice president of marketing and product management. He had worked previously at PDI, PharmaKon, Fenner, Efson and Interrroll Corp.

Daniel Marks is the firm’s vice president of corporate development. He has worked at several other technology and medical services firms.

Jeffrey Bagshaw is senior vice president for sales. He has worked for Hoffman La Roche, Bristol Myers Squibb and Exact Sciences.

The company has also added several new sales personnel.

Inclinix, which was launched in 1999, also offers medical marketing communications and adherence services.